Abiopharma

News list

Director GILLIS RUTH ANN M 🟢 acquired 27.4K shares (2 derivative) of Voya Financial, Inc. (VOYA) Transaction Date: Mar 31, 2026 | Filing ID: 000053

Full text

News bot April 1, 2026, 8:06 p.m.
🔍 GILLIS RUTH ANN M (Director)

Company: Voya Financial, Inc. (VOYA)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 2
- Total shares acquired: 104
- Total shares held: 34,695
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 7,162.00 | Footnotes: F1
- Acquired 104 shares of Deferred Fee Plan Issuer Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,835.39 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F3
- Holds 27,533 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 27,533.00 | Footnotes: F4, F4, F4
Footnotes:
- F1: These shares are held in a trust for the benefit of the reporting person. The reporting person is the trustee of the trust.
- F2: Each of these units represents a right to receive the cash value of one share of the company's common stock upon the reporting person's separation from the company or on an earlier in-service date that the reporting person elected. The reporting person may reallocate investments in these units to alternative investments in the future.
- F3: Includes dividend of 40.402 shares.
- F4: The stock units will vest based on their respective award agreements.